VIA
TIL icon

Vident Investment Advisory’s Instil Bio TIL Stock Holding History

Vident Investment Advisory’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,293
Closed -$609K – 1335
2022
Q3 		$609K Sell
6,293
-675
-10% -$77.2K 0.02% 728
2022
Q2 		$644K Buy
6,968
+3,505
+101% +$496K 0.02% 782
2022
Q1 		$745K Buy
3,463
+577
+20% +$135K 0.02% 807
2021
Q4 		$988K Sell
2,886
-1,465
-34% -$565K 0.03% 711
2021
Q3 		$1.56M Sell
4,351
-311
-7% -$116K 0.05% 537
2021
Q2 		$1.8M Buy
+4,662
New +$1.73M 0.05% 453

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $15.6M AUM 52.53% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vident Investment Advisory's TIL Position: Q4 2022 in Review

Vident Investment Advisory sold out of Instil Bio (TIL) in Q4 2022, closing a stake of 6,293 shares — an estimated $609K sold.

Vident Investment Advisory first reported a position in TIL in Q2 2021 and held it in 6 quarters. The position peaked at $1.8M in Q2 2021. 78 funds tracked by Wall St. Rank hold TIL as of Q4 2022.

  • Vident Investment Advisory reported no remaining Instil Bio position as of Q4 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 6,293 Instil Bio shares in Q4 2022, an estimated $609K.
  • Vident Investment Advisory first reported a position in Instil Bio in Q2 2021 and held it in 6 quarters.
  • Vident Investment Advisory's Instil Bio position peaked at $1.8M in Q2 2021.
  • 78 funds tracked by Wall St. Rank held Instil Bio as of Q4 2022.

Based on Vident Investment Advisory's 13F filing for Q4 2022, filed 14 Feb 2023.